骨折风险增高骨质疏松患者的识别与管理:ESCEO专家共识会议成果
欧洲骨质疏松和骨关节炎临床与经济学会(ESCEO)工作组召开专家共识会议,综述欧洲骨质疏松的流行病学与医疗管理现状。会议结论认为实施全球骨折预防策略是迫切需求,未来研究应聚焦于识别即刻骨折的具体风险因素、高骨折风险期及最适合高风险患者的治疗。
要点
- 尽管有效治疗手段可用,骨质疏松治疗接受率低且持续下降,尤其是二级骨折预防。
- 存在显著治疗缺口,急需解决以减少疾病负担。
核心结论
- 实施全球骨折预防策略是迫切需求。
- 未来研究应聚焦于识别即刻骨折的具体风险因素、高骨折风险期、骨折风险增高的患者以及最适合此类高风险患者的治疗和初级、二级、三级医疗中的最佳实施策略。
研究设计与样本
- 欧洲骨质疏松和骨关节炎临床与经济学会(ESCEO)召集工作组召开专家共识会议,综述当前关于骨质疏松流行病学和负担以及欧洲医疗管理模式的资料。
主要发现
- 尽管有效治疗手段可用,骨质疏松治疗接受率低且持续下降,尤其是二级骨折预防方面,首次骨折后后续骨折风险高。
- 受益于治疗的患者与接受治疗的患者之间存在显著治疗缺口。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: Osteoporosis represents a significant and increasing healthcare burden in Europe, but most patients at increased risk of fracture do not receive medication, resulting in a large treatment gap. Identification of patients who are at particularly high risk will help clinicians target appropriate treatment more precisely and cost-effectively, and should be the focus of future research. INTRODUCTION: The purpose of the study was to review data on the identification and treatment of patients with osteoporosis at increased risk of fracture. METHODS: A working group convened by the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis met to review current data on the epidemiology and burden of osteoporosis and the patterns of medical management throughout Europe. RESULTS: In Europe in 2010, the cost of managing osteoporosis was estimated at €37 billion and notably the costs of treatment and long-term care of patients with fractures were considerably higher than the costs for pharmacological prevention. Despite the availability of effective treatments, the uptake of osteoporosis therapy is low and declining, in particular for secondary fracture prevention where the risk of a subsequent fracture following a first fracture is high. Consequently, there is a significant treatment gap between those who would benefit from treatment and those who receive it, which urgently needs to be addressed so that the burden of disease can be reduced. CONCLUSIONS: Implementation of global fracture prevention strategies is a critical need. Future research should focus on identifying specific risk factors for imminent fractures, periods of high fracture risk, patients who are at increased risk of fracture and therapies that are most suited to such high-risk patients and optimal implementation strategies in primary, secondary and tertiary care.
引用
- Kanis JA, Cooper C, Rizzoli R, et al. Identification and management of patients at increased risk of osteoporotic fracture: outcomes of an ESCEO expert consensus meeting. Osteoporos Int. 2017. PMID: 28451733. doi:10.1007/s00198-017-4009-0
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。